Metropolitan Life Insurance Company (MetLife)’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-8,900
| Closed | -$604K | – | 2605 |
|
|
2019
Q3 | $604K | Buy |
8,900
+1,613
| +22% | +$109K | 0.01% | 1181 |
|
|
2019
Q2 | $424K | Buy |
7,287
+526
| +8% | +$30.6K | 0.01% | 1410 |
|
|
2019
Q1 | $474K | Sell |
6,761
-199
| -3% | -$13.9K | 0.01% | 1338 |
|
|
2018
Q4 | $448K | Hold |
6,960
| – | – | 0.01% | 1259 |
|
|
2018
Q3 | $489K | Hold |
6,960
| – | – | 0.01% | 1365 |
|
|
2018
Q2 | $351K | Hold |
6,960
| – | – | 0.01% | 1554 |
|
|
2018
Q1 | $218K | Hold |
6,960
| – | – | ﹤0.01% | 1842 |
|
|
2017
Q4 | $238K | Sell |
6,960
-6,282
| -47% | -$215K | ﹤0.01% | 1799 |
|
|
2017
Q3 | $425K | Hold |
13,242
| – | – | ﹤0.01% | 1795 |
|
|
2017
Q2 | $431K | Hold |
13,242
| – | – | ﹤0.01% | 1810 |
|
|
2017
Q1 | $417K | Hold |
13,242
| – | – | ﹤0.01% | 1782 |
|
|
2016
Q4 | $389K | Hold |
13,242
| – | – | ﹤0.01% | 1898 |
|
|
2016
Q3 | $383K | Hold |
13,242
| – | – | ﹤0.01% | 1874 |
|
|
2016
Q2 | $343K | Hold |
13,242
| – | – | ﹤0.01% | 1935 |
|
|
2016
Q1 | $328K | Hold |
13,242
| – | – | ﹤0.01% | 1841 |
|
|
2015
Q4 | $466K | Hold |
13,242
| – | – | ﹤0.01% | 1662 |
|
|
2015
Q3 | $280K | Hold |
13,242
| – | – | ﹤0.01% | 2025 |
|
|
2015
Q2 | $368K | Sell |
13,242
-757
| -5% | -$21K | ﹤0.01% | 1965 |
|
|
2015
Q1 | $428K | Hold |
13,999
| – | – | ﹤0.01% | 1635 |
|
|
2014
Q4 | $448K | Hold |
13,999
| – | – | ﹤0.01% | 1837 |
|
|
2014
Q3 | $396K | Hold |
13,999
| – | – | ﹤0.01% | 1869 |
|
|
2014
Q2 | $384K | Hold |
13,999
| – | – | ﹤0.01% | 2031 |
|
|
2014
Q1 | $369K | Hold |
13,999
| – | – | ﹤0.01% | 2014 |
|
|
2013
Q4 | $410K | Hold |
13,999
| – | – | ﹤0.01% | 1942 |
|
|
2013
Q3 | $428K | Hold |
13,999
| – | – | ﹤0.01% | 1855 |
|
|
2013
Q2 | $444K | Buy |
+13,999
| New | +$444K | ﹤0.01% | 1769 |
|